Pasireotide induces proteins related to autophagy in cancer cells

Madan Sigdel1, Saikat Fakir1, Md Matiur Rahman Sarker1

  • 1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA.

Endocrine
|July 10, 2026
PubMed
Abstract

Insights

Pasireotide (PAS), a synthetic somatostatin analog, was found to increase autophagy-related proteins in cancer cells. These findings suggest PAS may exert beneficial effects in cancer by modulating autophagy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Autophagy is a cellular process involved in maintaining homeostasis.
  • Dysregulation of autophagy is implicated in various cancers.
  • Synthetic somatostatin analogs (SSAs) are used in cancer therapy.

Purpose of the Study:

  • To investigate if Pasireotide (PAS), an SSA, influences autophagy-related proteins in cancer cells.
  • To explore the potential role of autophagy in the anti-cancer effects of PAS.

Main Methods:

  • Human cancer cell lines (MDA-MB-468 and HeLa) were treated with PAS or a vehicle control.
  • Cells were analyzed at different time points (8, 24, and 32 hours).
  • Western blot analysis was used to quantify changes in autophagy-related protein expression.

Main Results:

  • PAS treatment significantly increased the expression of autophagy-related proteins ATG-3, ATG-7, and Beclin-1.
  • These effects were observed in both MDA-MB-468 and HeLa cancer cell lines.
  • The induction of these proteins suggests PAS impacts the autophagic pathway.

Conclusions:

  • The study indicates that Pasireotide (PAS) can induce autophagy-related proteins in cancer cells.
  • Autophagy modulation may be a key mechanism underlying the anti-cancer effects of PAS.
  • Further research is warranted to fully elucidate the mechanisms involved.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...